SARS-CoV-2

SARS-CoV-2

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • COVID-19: No deal yet to access “90% effective” vaccine tested in South Africa

    The head of the South African arm of a key COVID-19 vaccine clinical trial is “full of pride” for the teams’ part in the research which has shown the vaccine candidate to be more than 90% effective according to early findings released this week. It however remains unclear whether the vaccine will be available in…

    ·

  • As COVID-19 numbers fall, much remains uncertain

    How many people have actually died of COVID-19 in South Africa and what do we know about the possibility of a second wave? As the first, and hopefully the only, substantial wave of infections and death recedes, Spotlight Editor Marcus Low assesses the many remaining uncertainties.

    ·

  • COVID-19: High prevalence found in Cape Town antibody study

    Initial results from an antibody survey conducted in the Cape Town Metro indicate that of 2 700 pregnant women and people living with HIV making use of the public healthcare system, 40% have previously been infected with SARS-CoV-2. Adele Baleta has the details.

    ·

  • COVID-19: What we know about SA’s 33 000 excess deaths so far

    Between the beginning of May and the first week of August, there have been over 33 000 excess deaths in South Africa. This is over three times the number of confirmed COVID-19 deaths. Kathryn Cleary asked the experts what we do and do not know about what so many people are dying of.

    ·

  • COVID-19: Understanding immunity and what it means for a vaccine

    Immunity to COVID-19 is much more interesting and much more complicated than simply something you do or do not have. Kathryn Cleary spoke to two experts about what we know about COVID-19 immunity and the implications of that for antibody testing and the development of vaccines.

    ·

  • Despite significant challenges, SAHPRA is on the right track

    Recently the South African Health Products Regulatory Authority was criticised for not approving laboratory-based SARS-CoV-2 antibody tests. Spotlight Editor Marcus Low argues that despite the regulator’s capacity constraints, its flexible conservatism is something to be grateful for.

    ·

  • COVID-19: What is the risk from waste?

    Are waste service workers becoming infected with SARS-CoV-2 through their work? Is handling household waste an occupational hazard? Are the precautionary measures introduced by municipalities sufficient? Professor Wolfgang Preiser explains the science and puts the risks in perspective.

    ·

  • COVID-19: How PE waste pickers navigate lockdown and hunger

    Hundreds of people daily search for recyclable materials to sell and food to eat at Arlington and Uitenhage waste disposal sites in Port Elizabeth. Luvuyo Mehlwana spoke to waste pickers about their fears of contracting COVID-19 from waste and to experts about the risks of this happening.

    ·

  • COVID-19: The touching story of Nurse Angy Rabothatha

    Testing positive for SARS-CoV-2 can be frightening and traumatic. Nurse Angy Rabothatha is among the many nurses who are part of government’s trace and support teams who help people with COVID-19 on their journey. She shared her story with Biénne Huisman.

    ·

  • A convenient untruth: The TB Proof healthcare worker

    We were told the planned release date for an occupational health policy to protect healthcare workers was World tuberculosis Day, 24 March 2017. Three World TB Days later and with a new epidemic claiming the lives of healthcare workers we are still waiting for the policy, writes Dr Arne von Delft.

    ·